ID: ALA4451213

Max Phase: Preclinical

Molecular Formula: C21H16FN3O

Molecular Weight: 345.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN1C(=O)c2ncccc2-c2cc(-c3ccc(F)nc3)ccc2C12CC2

Standard InChI:  InChI=1S/C21H16FN3O/c1-25-20(26)19-15(3-2-10-23-19)16-11-13(14-5-7-18(22)24-12-14)4-6-17(16)21(25)8-9-21/h2-7,10-12H,8-9H2,1H3

Standard InChI Key:  PCKLKLKHDKJMKN-UHFFFAOYSA-N

Associated Targets(Human)

Metabotropic glutamate receptor 3 732 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.38Molecular Weight (Monoisotopic): 345.1277AlogP: 4.02#Rotatable Bonds: 1
Polar Surface Area: 46.09Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.83CX LogP: 3.19CX LogD: 3.19
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -0.20

References

1. Kargbo RB..  (2019)  Allosteric mGluR3 Modulators for the Treatment of Psychiatric Disorders.,  10  (2): [PMID:30783491] [10.1021/acsmedchemlett.8b00619]

Source